SANOFI-ADR (SNY)
US80105N1054 - ADR
Taking everything into account, SNY scores 6 out of 10 in our fundamental rating. SNY was compared to 198 industry peers in the Pharmaceuticals industry. SNY scores excellent on profitability, but there are some minor concerns on its financial health. SNY is valued quite cheap, while showing a decent growth score. This is a good combination! SNY also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year SNY was profitable.
In the past year SNY had a positive cash flow from operations.
SNY had positive earnings in each of the past 5 years.
SNY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 7.85%, SNY belongs to the best of the industry, outperforming 90.82% of the companies in the same industry.
Looking at the Return On Equity, with a value of 13.40%, SNY belongs to the top of the industry, outperforming 90.31% of the companies in the same industry.
SNY's Return On Invested Capital of 12.90% is amongst the best of the industry. SNY outperforms 91.84% of its industry peers.
SNY had an Average Return On Invested Capital over the past 3 years of 7.48%. This is significantly below the industry average of 16.40%.
The last Return On Invested Capital (12.90%) for SNY is above the 3 year average (7.48%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.85% | ||
| ROE | 13.4% | ||
| ROIC | 12.9% |
ROA(3y)5.35%
ROA(5y)5.85%
ROE(3y)9.18%
ROE(5y)10.34%
ROIC(3y)7.48%
ROIC(5y)6.88%
1.3 Margins
SNY's Profit Margin of 14.17% is amongst the best of the industry. SNY outperforms 90.31% of its industry peers.
SNY's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 23.81%, SNY belongs to the top of the industry, outperforming 91.84% of the companies in the same industry.
In the last couple of years the Operating Margin of SNY has grown nicely.
The Gross Margin of SNY (69.78%) is better than 75.51% of its industry peers.
In the last couple of years the Gross Margin of SNY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.81% | ||
| PM (TTM) | 14.17% | ||
| GM | 69.78% |
OM growth 3Y4.23%
OM growth 5Y5%
PM growth 3Y-29.3%
PM growth 5Y-0.74%
GM growth 3Y0.92%
GM growth 5Y0.41%
2. Health
2.1 Basic Checks
SNY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SNY has about the same amout of shares outstanding than it did 1 year ago.
SNY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SNY has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of SNY is 2.55, which is a good value as it means it would take SNY, 2.55 years of fcf income to pay off all of its debts.
SNY has a Debt to FCF ratio of 2.55. This is amongst the best in the industry. SNY outperforms 92.35% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that SNY is not too dependend on debt financing.
SNY's Debt to Equity ratio of 0.22 is in line compared to the rest of the industry. SNY outperforms 43.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 2.55 | ||
| Altman-Z | N/A |
ROIC/WACC1.87
WACC6.91%
2.3 Liquidity
SNY has a Current Ratio of 1.28. This is a normal value and indicates that SNY is financially healthy and should not expect problems in meeting its short term obligations.
SNY's Current ratio of 1.28 is on the low side compared to the rest of the industry. SNY is outperformed by 80.10% of its industry peers.
A Quick Ratio of 0.38 indicates that SNY may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.38, SNY is doing worse than 94.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.38 |
3. Growth
3.1 Past
SNY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.70%.
SNY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.19% yearly.
SNY shows a small growth in Revenue. In the last year, the Revenue has grown by 2.08%.
The Revenue has been growing slightly by 5.42% on average over the past years.
EPS 1Y (TTM)-1.7%
EPS 3Y10.81%
EPS 5Y8.19%
EPS growth Q2Q-2.92%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y7.52%
Revenue growth 5Y5.42%
Revenue growth Q2Q1.24%
3.2 Future
The Earnings Per Share is expected to grow by 6.56% on average over the next years.
SNY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.62% yearly.
EPS Next Y-4.03%
EPS Next 2Y4.37%
EPS Next 3Y5.4%
EPS Next 5Y6.56%
Revenue Next Year5.23%
Revenue Next 2Y6.13%
Revenue Next 3Y5.66%
Revenue Next 5Y4.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.62, the valuation of SNY can be described as very reasonable.
91.33% of the companies in the same industry are more expensive than SNY, based on the Price/Earnings ratio.
SNY is valuated cheaply when we compare the Price/Earnings ratio to 24.80, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.07, which indicates a very decent valuation of SNY.
90.31% of the companies in the same industry are more expensive than SNY, based on the Price/Forward Earnings ratio.
SNY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.62 | ||
| Fwd PE | 11.07 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SNY is valued cheaper than 95.92% of the companies in the same industry.
85.71% of the companies in the same industry are more expensive than SNY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.99 | ||
| EV/EBITDA | 5.4 |
4.3 Compensation for Growth
SNY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.3
EPS Next 2Y4.37%
EPS Next 3Y5.4%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.34%, SNY is a good candidate for dividend investing.
SNY's Dividend Yield is rather good when compared to the industry average which is at 4.36. SNY pays more dividend than 96.43% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, SNY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.34% |
5.2 History
The dividend of SNY has a limited annual growth rate of 3.31%.
SNY has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.31%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
44.90% of the earnings are spent on dividend by SNY. This is a bit on the high side, but may be sustainable.
SNY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP44.9%
EPS Next 2Y4.37%
EPS Next 3Y5.4%
SANOFI-ADR
NASDAQ:SNY (4/19/2024, 1:48:07 PM)
46.395
+1.01 (+2.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap115.82B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.34% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.62 | ||
| Fwd PE | 11.07 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.85% | ||
| ROE | 13.4% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 23.81% | ||
| PM (TTM) | 14.17% | ||
| GM | 69.78% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1.7%
EPS 3Y10.81%
EPS 5Y
EPS growth Q2Q
EPS Next Y-4.03%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.08%
Revenue growth 3Y7.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y